Advanced/metastatic gastroesophageal adenocarcinoma

Clinical trials for Advanced/metastatic gastroesophageal adenocarcinoma explained in plain language.

Never miss a new study

Get alerted when new Advanced/metastatic gastroesophageal adenocarcinoma trials appear

Sign up with your email to follow new studies for Advanced/metastatic gastroesophageal adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Triple-Drug cocktail aims to beat stomach cancer

Disease control Completed

This phase 3 trial tested whether adding lenvatinib and pembrolizumab to standard chemotherapy helps people with advanced gastroesophageal cancer live longer. About 895 participants received either the new combination or chemo alone. The study is complete, and results will show i…

Matched conditions: ADVANCED/METASTATIC GASTROESOPHAGEAL ADENOCARCINOMA

Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jun 27, 2026 12:25 UTC

Advanced/metastatic gastroesophageal adenocarcinoma

Get alerted when new Advanced/metastatic gastroesophageal adenocarcinoma trials appear

Triple-Drug cocktail aims to beat stomach cancer